Bezafibrate reduces incidence, delays onset of type 2 diabetes

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1516, 2005-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Soy-based supplement reduces lipid levels in type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Liraglutide reduces HbA1c and bodyweight in type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1504, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Irbesartan reduces progression of renal disease in type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1290, 2001-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Increasing Incidence of Type 2 Diabetes in Children and Adolescents: Treatment Considerations

By Rosenbloom A.L.  

Pediatric Drugs, Vol. 4, Iss. 4, 2002-01 ,pp. : 209-221

Adis International

Access to resources Recommend Favorite

The L/N-type Calcium Channel Blocker, Cilnidipine, Reduces Heart Rate and Albuminuria in Patients with Type 2 Diabetes

By Tanaka M  

The Journal of International Medical Research, Vol. 38, Iss. 2, 2010-03 ,pp. : 602-610

Field House Publishing

Access to resources Recommend Favorite